New York Life Investment Management’s Trane Technologies TT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32,786
Closed -$13.8M 853
2025
Q3
$13.8M Sell
32,786
-658
-2% -$281K 0.12% 155
2025
Q2
$14.6M Buy
33,444
+227
+0.7% +$89.6K 0.14% 137
2025
Q1
$11.2M Sell
33,217
-288
-0.9% -$104K 0.11% 164
2024
Q4
$12.4M Sell
33,505
-28
-0.1% -$11.1K 0.12% 153
2024
Q3
$13M Sell
33,533
-961
-3% -$333K 0.13% 158
2024
Q2
$11.3M Buy
34,494
+174
+0.5% +$55.3K 0.11% 169
2024
Q1
$10.3M Sell
34,320
-1,309
-4% -$355K 0.1% 181
2023
Q4
$8.69M Sell
35,629
-12,673
-26% -$2.77M 0.09% 200
2023
Q3
$9.8M Sell
48,302
-1,915
-4% -$384K 0.11% 171
2023
Q2
$9.6M Sell
50,217
-507
-1% -$90K 0.1% 190
2023
Q1
$9.33M Buy
50,724
+14,590
+40% +$2.65M 0.1% 201
2022
Q4
$6.07M Sell
36,134
-249
-0.7% -$41.1K 0.07% 279
2022
Q3
$5.27M Sell
36,383
-485
-1% -$72.5K 0.06% 297
2022
Q2
$4.79M Buy
+36,868
New +$5.1M 0.06% 321

Other funds holding TT

New York Life Investment Management's TT Position: Q4 2025 in Review

New York Life Investment Management sold out of Trane Technologies (TT) in Q4 2025, closing a stake of 32,786 shares — an estimated $13.8M sold.

New York Life Investment Management first reported a position in TT in Q2 2022 and held it in 14 quarters. The position peaked at $14.6M in Q2 2025. 1,705 funds tracked by Wall St. Rank hold TT as of Q4 2025.

  • New York Life Investment Management reported no remaining Trane Technologies position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 32,786 Trane Technologies shares in Q4 2025, an estimated $13.8M.
  • New York Life Investment Management first reported a position in Trane Technologies in Q2 2022 and held it in 14 quarters.
  • New York Life Investment Management's Trane Technologies position peaked at $14.6M in Q2 2025.
  • 1,705 funds tracked by Wall St. Rank held Trane Technologies as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.